Kunal Potnis, MD

Incoming fellow @FredHutch/@UW | PGY-3 @YaleIMed | @YaleMed '23, @DukeU '17 | Interested in intersection of hematology/oncology, economics, & policy

[Kunal Potnis, MD @KunalPotnis]

So wonderful to meet in person today at ASCO -- can't wait for the adventure ahead in Seattle!

[Anh Lam (she/her) @anhbl9]

Got to meet my future co-fellow Dr Kunal Potnis at #ASCO26!! Loved that we got to also spend some time with our @fredhutch PD Dr Menon this afternoon🫶

Very excited for this next chapter for us and to be in Seattle very soon!

[Kunal Potnis, MD @KunalPotnis]

@Tyler_B_Jensen @BrighamMedRes Congratulations Tyler, so excited for you!!!

[Kunal Potnis, MD @KunalPotnis]

Thank you @OncLearnNetwork for the opportunity to discuss our team's recent #breastcancer cost-effectiveness work at #ASCO25

[Oncology Learning Network @OncLearnNetwork]

Kunal Potnis, MD, discusses an analysis of the cost-effectiveness of #ribociclib plus endocrine therapy compared to endocrine therapy alone among patients with HR-positive, HER2-negative early breast cancer. Learn more: https://t.co/2RwsJ5yDBK

#medtwitter #onctwitter

[Soki Kashima @KashimaMDPhD]

We are now diving into the tumor-gut axis in the aRCC field as well;

Lower levels of MAdCAM-1 in plasma are associated with more aggressive RCC & are one of the most promising prognostic biomarkers by @ReneeSaliby

@ASCO @BraunMDPhD @DrChoueiri @YaleCancer @YaleMed

[Yale Cancer Center @YaleCancer]

.@KunalPotnis shares that at current pricing, ribociclib w endocrine therapy is not expected to be cost-effective compared to endocrine therapy alone for pts with HR+ HER2- early #breastcancer in the US. #ASCO25 @GeorgeGoshuaMD @SmilowCancer @YaleMed @OncoAlert @YaleBreast
https://t.co/hjFrZkoNNA

[Kunal Potnis, MD @KunalPotnis]

@ABidikianMD @CIBMTR @ASTCT Amazing Aram, congrats!

[Juan Carlos Batlle, MD @juancbatlle]

Great CCU block! ✅ @TradIMYale
Missing our fellows @daeyongp92 @OmarosisFugax

[Yale Cancer Center @YaleCancer]

.@KunalPotnis reveals that at the current pricing, eltrombopag plus traditional immunosuppressive therapy is unlikely to be a cost-effective treatment for adults with severe aplastic anemia in the US. #ASH24 @GeorgeGoshuaMD @YaleHematology @SmilowCancer https://t.co/ztySpPoq7K

[Kunal Potnis, MD @KunalPotnis]

@MarkDSiegel1 @GeorgeGoshuaMD @TradIMYale @YaleIMed Thank you, Dr. Siegel -- always appreciate your generous support!

[Kunal Potnis, MD @KunalPotnis]

Excited to see this article with @GeorgeGoshuaMD out in @BulletinAtomic, where we explore how adding a health equity lens to valuation can help harness the potential of gene therapies around the world

@YaleMed @YaleIMed @TradIMYale @MarkDSiegel1

[Bulletin of the Atomic Scientists @BulletinAtomic]

CRISPR therapies can treat disease but cost millions. An equity-based approach could bring them to more people.

Read the new article from @KunalPotnis and @GeorgeGoshuaMD:
https://t.co/wScznmGMR3

[Kunal Potnis, MD @KunalPotnis]

@montanomd @accpchest Congrats Mason!

[Aram Bidikian @ABidikianMD]

Our recent review on targeted therapies in #MDS discussing current landscape and future directions https://t.co/jKYLjFD9IK. Special thanks to Dr. @Dr_AmerZeidan and all co-authors for their guidance and support @TradIMYale @YaleCancer @YaleHematology

[Kunal Potnis, MD @KunalPotnis]

@carsalpajarillo @YaleVAMOS @YaleCardiology Congratulations Carmen, really excited that you'll be sticking around!

[Kunal Potnis, MD @KunalPotnis]

Congratulations and welcome to the newest members of the @TradIMYale family!!! Can't wait to meet and work with you all in the near future. @YaleIMed #MatchDay2024

[Yale Internal Medicine @YaleIMed]

Congratulations to the newly matched residents in our Internal Medicine Traditional Residency Program! Welcome to @YaleMed @Yale @YNHH!

🧵 #MatchDay2024 #Residency #MedTwitter #Match2024

@MarkDSiegel1 @TradIMYale

[Yale Cancer Center @YaleCancer]

In recognition of his innovation, @GeorgeGoshuaMD has been named a Young Explorer Award finalist by NOMIS & @ScienceMagazine. Dr. Goshua shared how mathematical models can hold the key to equitable patient care in, "Napkin math can change the world." https://t.co/tn3caIs4k5

[Kunal Potnis, MD @KunalPotnis]

@AyeshaButtMD Thank you, @AyeshaButtMD!

[Kunal Potnis, MD @KunalPotnis]

Awesome time presenting work examining the #costeffectiveness of novel therapies (BiTE versus CAR-T) for relapsed/refractory multiple myeloma at #SMDM23 in Philadelphia this weekend

[Kunal Potnis, MD @KunalPotnis]

@ssanchezneuro Thanks @ssanchezneuro!

[Kunal Potnis, MD @KunalPotnis]

@GeorgeGoshuaMD @YaleCancer @YaleIMed You are so kind, @GeorgeGoshuaMD -- your support has truly been invaluable!

[Kunal Potnis, MD @KunalPotnis]

@MarkDSiegel1 @YaleIMed Thanks so much, @MarkDSiegel1!

[Kunal Potnis, MD @KunalPotnis]

Big thanks to team that includes @sfhYALE, @GeorgeGoshuaMD, & @YuxinLiu_03 (along with #DrBar and #Karthik). Also grateful to @TradIMYale and @YaleIMed for their support!